Oral vaccination with recombinant Listeria monocytogenes expressing human papillomavirus type 16 E7 can cause tumor growth in mice to regress

Chih Wei Lin, Jen Yi Lee, Yeou Ping Tsao, Che Piao Shen, Hung Cheng Lai, Show Li Chen

研究成果: 雜誌貢獻文章同行評審

52 引文 斯高帕斯(Scopus)

摘要

Listeria monocytogenes is a Gram-positive, facultative intra-cellular bacterium with the ability to present secreted proteins to the major histocompatibility complex class I pathway to stimulate cell-mediated immune response. In our study, we constructed the recombinant L. monocytogenes encoding human papillomavirus type 16 E7 gene (rLM-E7). When orally administered to syngeneic mice, rLM-E7 could induce a cytotoxic T-lymphocyte (CTL) response. Furthermore, in vitro flow cytometric assay and in vivo immune deficiency assays showed that rLM-E7 could prevent and eradicate tumor growth via CD8+-dependent CTLs. Hence, the potency of rLM-E7 as a therapeutic vaccine for cervical cancer is the result of the induction E7-specific cell-mediated immunity by L. monocytogenes. In addition to potency, this vaccine also offers ease of administration and reduced cost of production compared with other vaccines formulated for injection. Thus, L. monocytogenes encoding HPV-16 E7 may be a useful oral vaccine for cervical cancer treatment.

原文英語
頁(從 - 到)629-637
頁數9
期刊International Journal of Cancer
102
發行號6
DOIs
出版狀態已發佈 - 十二月 20 2002
對外發佈

ASJC Scopus subject areas

  • 癌症研究
  • 腫瘤科

指紋

深入研究「Oral vaccination with recombinant Listeria monocytogenes expressing human papillomavirus type 16 E7 can cause tumor growth in mice to regress」主題。共同形成了獨特的指紋。

引用此